Telomerase reverse transcriptase (TERT) promoter mutation was found to be an independent risk factor for recurrence and mortality in well differentiated thyroid cancers [30], and, in combination with the BRAF-V600E mutation, TERT promoter mutation is associated with an increased risk of structural disease recurrence [22, 31]. The gene discussed is TERT; the disease is thyroid gland carcinoma.